About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Enrolling By InvitationNANCT07165626

Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy

The goal of this interventional study is to assess the dynamics of structural and functional retinal changes in eyes with epiretinal membrane (ERM) after pars plana vitrectomy (PPV). Other study objec...

Lead sponsor: Pomeranian Medical University Szczecin•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pomeranian Medical University Szczecin

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Epiretinal membrane (ERM) - either associated with metamorphopsia or causing a marked reduction in best corrected visual acuity
•Pseudophakia

Exclusion Criteria

•Coexisting ocular or retinal diseases other than ERM
•Evidence of ocular inflammation or any active intraocular inflammatory process

Related studies

Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL

NCT06893965 · Macular Diseases

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

NCT05145491 · Epiretinal Membrane

Intraoperative OCT Guidance of Intraocular Surgery II

NCT03713268 · Macular Holes, Epiretinal Membrane, and more

Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery

NCT07178639 · Macular Oedema, Cataract Surgery, and more

Functional IOL Implantation in Patients with Epiretinal Membrane

NCT06719739 · Cataract, Intraocular Lens Complication, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 10, 2025Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

PhaseNA

Enrollment100

Start dateMay 2024

Last updatedSep 10, 2025

Condition

Epiretinal Membrane Macular Oedema Macular Diseases Retinal Diseases

Locations shown

First Department of Ophthalmology, Pomeranian Medical University

Szczecin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions